Interestingly, in pancreatic cancer, BNIP3 downregulation contributes to chemotherapy resistance and is associated with poor patient prognosis, implying a tumor-suppressing role of BNIP3 [61]. Here, BNIP3 is linked to pancreatic neoplasm.